Insider · CIK 0001331339

Powell Fred M

Reports to the SEC for 4 companies · PLYMOUTH MEETING, PA

sec.gov

Transactions

Companies

Filings

CIK

0001331339

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-13	LAVA Therapeutics NVD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−65K sh	—	—	0
2025-11-13	LAVA Therapeutics NVShare Options (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	—	—	0
2025-02-13	LAVA Therapeutics NVShare Options (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	124,700
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−204K sh	$5.60	−$1.14M	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−124K sh	$5.60	−$696K	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−150K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−218K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−177K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−254K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−182K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−164K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Executive Vice President & CFO	DDisposition to Issuer	−587K sh	$5.60	−$3.29M	0
2022-03-03	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+27.8K sh	—	—	802,542
2022-03-03	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−11.5K sh	$3.80	−$43.7K	791,036
2022-02-16	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+24.6K sh	—	—	786,258
2022-02-16	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−11.5K sh	$3.66	−$42.1K	774,762
2021-06-13	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−11.9K sh	$4.45	−$52.9K	761,652
2021-06-13	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−17.3K sh	$4.45	−$77.1K	773,532
2021-06-10	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+86K sh	$4.42	+$380K	790,859
2021-06-10	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+164K sh	—	—	163,963
2021-06-08	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−12K sh	$4.39	−$52.9K	704,886
2021-03-01	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−19.9K sh	$4.50	−$89.5K	716,931
2021-03-01	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+45.8K sh	—	—	736,830
2021-02-17	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−35.8K sh	$4.73	−$169K	691,001
2021-02-17	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+80.4K sh	—	—	726,830
2020-11-12	ANTARES PHARMA, INC.P Purchase	Executive Vice President & CFO	PPurchase	+16.4K sh	$2.85	+$46.7K	646,465
2020-06-13	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−8,564 sh	$2.78	−$23.8K	630,065
2020-06-11	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+254K sh	—	—	254,165
2020-06-11	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+132K sh	$2.73	+$360K	638,629
2020-06-08	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−8,683 sh	$3.13	−$27.2K	506,761
2020-06-07	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−9,609 sh	$3.12	−$30K	515,444
2020-02-19	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+63.2K sh	—	—	548,844
2020-02-19	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−23.8K sh	$3.53	−$84K	525,053
2019-06-13	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+90.4K sh	$2.92	+$264K	485,610
2019-06-13	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+182K sh	—	—	181,575
2019-06-08	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−8,684 sh	$2.81	−$24.4K	395,199
2019-06-07	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−9,609 sh	$2.81	−$27K	403,883
2018-06-08	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+177K sh	—	—	177,453
2018-06-08	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+91.7K sh	$2.70	+$248K	413,492
2018-06-07	ANTARES PHARMA, INC.F Tax Payment	Executive Vice President & CFO	FTax Payment	−9,609 sh	$2.70	−$25.9K	321,825
2017-06-09	ANTARES PHARMA, INC.P Purchase	Executive Vice President & CFO	PPurchase	+130K sh	$2.79	+$363K	331,434
2017-06-07	ANTARES PHARMA, INC.A Award	Executive Vice President & CFO	AAward	+101K sh	$2.66	+$270K	201,434
2017-06-07	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+218K sh	—	—	217,725
2016-12-09	ANTARES PHARMA, INC.P Purchase	Executive Vice President & CFO	PPurchase	+100K sh	$2.02	+$203K	100,000
2016-10-31	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Executive Vice President & CFO	AAward	+150K sh	—	—	150,000
2016-07-12	Celator Pharmaceuticals IncStock Option (right to buy)D Disposition to Issuer	VP and Chief Financial Officer	DDisposition to Issuer	−138K sh	$28.93	−$3.98M	0
2016-07-12	Celator Pharmaceuticals IncStock Option (right to buy)D Disposition to Issuer	VP and Chief Financial Officer	DDisposition to Issuer	−55K sh	$27.46	−$1.51M	0
2016-07-12	Celator Pharmaceuticals IncStock Option (right to buy)D Disposition to Issuer	VP and Chief Financial Officer	DDisposition to Issuer	−50K sh	$27.03	−$1.35M	0
2016-07-12	Celator Pharmaceuticals IncD Disposition to Issuer	VP and Chief Financial Officer	DDisposition to Issuer	−156K sh	$30.25	−$4.72M	0
2016-07-06	Celator Pharmaceuticals IncStock Option (right to buy)M Exercise/Conversion	VP and Chief Financial Officer	MExercise/Conversion	−71.9K sh	—	—	181,113

Recent filings

Accepted (ET)
Nov 174
Powell Fred M0001331339-25-000005
SEC(opens sec.gov)
Feb 184
Powell Fred M0001415889-25-004526
SEC(opens sec.gov)
May 264
Powell Fred M0000899243-22-019784
SEC(opens sec.gov)
Mar 44
Powell Fred M0001016169-22-000033
SEC(opens sec.gov)
Feb 184
Powell Fred M0001016169-22-000014
SEC(opens sec.gov)
Jun 144
Powell Fred M0001209191-21-040337
SEC(opens sec.gov)

Companies

Address

C/O BMP SUNSTONE CORPORATION 600 WEST GERMANTOWN PIKE

PLYMOUTH MEETING, PA, 19462